H. Mulec

5.5k total citations
20 papers, 1.5k citations indexed

About

H. Mulec is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, H. Mulec has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Nephrology. Recurrent topics in H. Mulec's work include Lipoproteins and Cardiovascular Health (7 papers), Chronic Kidney Disease and Diabetes (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). H. Mulec is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Chronic Kidney Disease and Diabetes (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). H. Mulec collaborates with scholars based in Sweden, United States and United Kingdom. H. Mulec's co-authors include S Björck, Mattias Aurell, Svend Aage Johnsen, G. Nyberg, Gunnela Nordén, Ola Samuelsson, Hans Herlitz, G. Granérus, Carolyn Knight‐Gibson and Lars Weiss and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Diabetologia.

In The Last Decade

H. Mulec

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Mulec Sweden 18 782 690 581 357 180 20 1.5k
Bertram L. Kasiske United States 11 840 1.1× 514 0.7× 573 1.0× 493 1.4× 109 0.6× 11 1.7k
S Chaithiraphan Thailand 11 442 0.6× 1.1k 1.6× 508 0.9× 296 0.8× 222 1.2× 32 1.7k
D Cordonnier France 19 717 0.9× 450 0.7× 367 0.6× 194 0.5× 126 0.7× 69 1.6k
Alessandro Roberto Dodesini Italy 13 686 0.9× 604 0.9× 678 1.2× 251 0.7× 126 0.7× 25 1.6k
Aneliya Parvanova Italy 14 775 1.0× 693 1.0× 693 1.2× 204 0.6× 146 0.8× 21 1.6k
Ilian Iliev Italy 15 769 1.0× 674 1.0× 677 1.2× 183 0.5× 169 0.9× 23 1.6k
María Ganeva Bulgaria 9 587 0.8× 843 1.2× 473 0.8× 168 0.5× 153 0.8× 23 1.5k
E. R. Mathiesen Denmark 15 1.1k 1.3× 730 1.1× 1.3k 2.2× 240 0.7× 159 0.9× 30 2.3k
Eberhard Ritz Germany 12 864 1.1× 502 0.7× 513 0.9× 193 0.5× 223 1.2× 12 1.8k
K. J. Schjoedt Denmark 13 415 0.5× 758 1.1× 909 1.6× 179 0.5× 235 1.3× 16 1.3k

Countries citing papers authored by H. Mulec

Since Specialization
Citations

This map shows the geographic impact of H. Mulec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Mulec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Mulec more than expected).

Fields of papers citing papers by H. Mulec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Mulec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Mulec. The network helps show where H. Mulec may publish in the future.

Co-authorship network of co-authors of H. Mulec

This figure shows the co-authorship network connecting the top 25 collaborators of H. Mulec. A scholar is included among the top collaborators of H. Mulec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Mulec. H. Mulec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alaupovic, Petar, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (2006). Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency. Kidney International. 69(10). 1865–1871. 18 indexed citations
2.
Eriksson, Ulf G., Susanne Johansson, Per‐Ola Attman, et al.. (2003). Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran. Clinical Pharmacokinetics. 42(8). 743–753. 42 indexed citations
3.
Samuelsson, Ola, Per‐Ola Attman, Carolyn Knight‐Gibson, et al.. (2002). Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency. American Journal of Kidney Diseases. 39(1). 67–75. 27 indexed citations
4.
Samuelsson, Ola, Per‐Ola Attman, Rutger Larsson, et al.. (2000). Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. Nephrology Dialysis Transplantation. 15(4). 481–486. 20 indexed citations
5.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1999). The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression. ˜The œNephron journals/Nephron journals. 82(4). 306–311. 26 indexed citations
6.
Mulec, H., et al.. (1998). The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. Nephrology Dialysis Transplantation. 13(3). 651–655. 53 indexed citations
7.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1998). Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.. Journal of the American Society of Nephrology. 9(8). 1482–1488. 93 indexed citations
8.
Samuelsson, Ola, H. Mulec, Carolyn Knight‐Gibson, et al.. (1997). Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrology Dialysis Transplantation. 12(9). 1908–1915. 179 indexed citations
9.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1997). Effect of Gemfibrozil on Lipoprotein Abnormalities in Chronic Renal Insufficiency: A Controlled Study in Human Chronic Renal Disease. Nephron. 75(3). 286–294. 21 indexed citations
10.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1996). Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure. Nephrology Dialysis Transplantation. 11(11). 2237–2243. 14 indexed citations
11.
Mulec, H., et al.. (1995). Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia. 38(2). 216–220. 39 indexed citations
12.
Mulec, H., Svend Aage Johnsen, & S Björck. (1994). Long-term enalapril treatment in diabetic nephropathy.. PubMed. 45. S141–4. 13 indexed citations
13.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1994). Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrology Dialysis Transplantation. 9(11). 1580–1585. 34 indexed citations
14.
Mulec, H., Svend Aage Johnsen, O. Wiklund, & S Björck. (1993). Cholesterol: A Renal Risk Factor in Diabetic Nephropathy. American Journal of Kidney Diseases. 22(1). 196–201. 97 indexed citations
15.
Björck, S, H. Mulec, Svend Aage Johnsen, Gunnela Nordén, & Mattias Aurell. (1992). Renal protective effect of enalapril in diabetic nephropathy.. BMJ. 304(6823). 339–343. 329 indexed citations
16.
Björck, S, H. Mulec, Svend Aage Johnsen, G. Nyberg, & Mattias Aurell. (1990). Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.. BMJ. 300(6729). 904–907. 83 indexed citations
17.
Björck, S, G. Nyberg, H. Mulec, et al.. (1986). Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.. BMJ. 293(6545). 471–474. 311 indexed citations
18.
Mulec, H., et al.. (1985). Thromboprophylactic Effect of Ticlopidine in Arteriovenous Fistulas for Haemodialysis. Scandinavian Journal of Urology and Nephrology. 19(1). 55–57. 46 indexed citations
19.
Mulec, H., et al.. (1984). Acute Renal Failure after Intoxication with Cortinarius Mushrooms. Human Toxicology. 3(4). 309–313. 23 indexed citations
20.
Herlitz, Hans, et al.. (1984). Captopril Treatment of Hypertension and Renal Failure in Systemic <i>Lupus erythematosus</i>. ˜The œNephron journals/Nephron journals. 38(4). 253–256. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertram L. Kasiske Breakdown of academic impact, for papers by S Chaithiraphan Breakdown of academic impact, for papers by D Cordonnier Breakdown of academic impact, for papers by Alessandro Roberto Dodesini Breakdown of academic impact, for papers by Aneliya Parvanova Breakdown of academic impact, for papers by Ilian Iliev Breakdown of academic impact, for papers by María Ganeva Breakdown of academic impact, for papers by E. R. Mathiesen Breakdown of academic impact, for papers by Eberhard Ritz Breakdown of academic impact, for papers by K. J. Schjoedt
Rankless by CCL
2026